• Study Comparing Corifollitropin Alfa and Modified Natural Cycles for Women with Subfertility and Low Ovarian Response

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium
  • Study on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Greece Hungary +6
  • Study on Personalized Dosing of Emicizumab for Patients with Congenital Hemophilia A

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Safety and Tolerability of CEB-01 in Patients with Pancreatic Cancer

    Recruiting

    2 1 1
    Investigated diseases:
    Spain
  • Study of Durvalumab alone and in combination with Tremelimumab in children with advanced solid tumors and blood cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on the Effects of Ozanimod in Patients with Relapsing-Remitting Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated drugs:
    Italy
  • Study on Self-Administration of Elranatamab for Patients with Multiple Myeloma at Home

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia Denmark France Germany +8
  • Study on Rituximab for Preventing Epstein-Barr Virus Infection and Lymphoproliferative Disorders in EBV-Negative Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated drugs:
    France
  • Study on ATX-01 for Adults Aged 18-64 with Myotonic Dystrophy Type 1 (DM1)

    Recruiting

    1 1
    Investigated diseases:
    France Italy The Netherlands Spain

powered by